PCVX - Vaxcyte GAAP EPS of -$0.91 November, 06 2023 05:51 PM Vaxcyte Inc. 2023-11-06 17:51:44 ET More on Vaxcyte Vaxcyte: End Of Phase 2 Meeting FDA Q4 Of 2023 To Get Ball Rolling Strong Financials And Pipeline Position Vaxcyte For Success For further details see: Vaxcyte GAAP EPS of -$0.91